Hospital District of Helsinki and Uusimaa
37
8
12
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
2.7%
1 terminated/withdrawn out of 37 trials
92.3%
+5.8% vs industry average
0%
0 trials in Phase 3/4
8%
1 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (37)
Hormonal Regulation of Cardiometabolic Health Study
Role: collaborator
Thermal Imaging in the Diagnosis of Acute Testicular Pain
Role: collaborator
Usability Study of Gestational and Postpartum Weight Management Program
Role: collaborator
Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression: the Prospective VASCUL-AID Study
Role: collaborator
Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
Role: collaborator
Immune Responses in Health Care Personnel
Role: collaborator
Online Training Course to Improve Evidence-based Leadership
Role: collaborator
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome
Role: collaborator
A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)
Role: collaborator
Youth Experiences and Health Study
Role: collaborator
Efficacy of First MTPJ Arthrodesis as a Treatment in Hallux Rigidus
Role: lead
Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery
Role: lead
The Outcome of Subthalamic Deep Brain Stimulation in Advanced Parkinson's Disease and Morphometry
Role: lead
Weight-bearing of Surgically Treated Acetabular Fractures.
Role: lead
Risk for Reoperation After First MTP Joint Arthrodesis
Role: lead
Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression
Role: collaborator
Spectroscopic Assessment of Intramyocardial Oxygen Saturation Feasibility During Open-heart Surgery
Role: collaborator
Comparison of Outcomes in Asleep and Awake DBS With a Directional Electrode
Role: lead
Directional Deep Brain Stimulation With Patients With Advanced Parkinson's Disease
Role: lead
Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines
Role: collaborator